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Objective: Framed in the patients’ engagement perspective, the current study aims to
determine the effects of group music therapy in addition to drug care in comparison
with drug care in addition to other non-expressive group activities in the treatment of
psychiatric outpatients.
Method: Participants (n = 27) with ICD-10 diagnoses of F20 (schizophrenia), F25
(schizoaffective disorders), F31 (bipolar affective disorder), F32 (depressive episode),
and F60 (specific personality disorders) were randomized to receive group music therapy
plus standard care (48 weekly sessions of 2 h) or standard care only. The clinical
measures included dosages of neuroleptics, benzodiazepines, mood stabilizers, and
antidepressants.
Results: The participants who received group music therapy demonstrated greater
improvement in drug dosage with respect to neuroleptics than those who did not
receive group music therapy. Antidepressants had an increment for both groups that
was significant only for the control group. Benzodiazepines and mood stabilizers did not
show any significant change in either group.
Conclusion: Group music therapy combined with standard drug care was effective for
controlling neuroleptic drug dosages in adult psychiatric outpatients who received group
music therapy. We discussed the likely applications of group music therapy in psychiatry
and the possible contribution of music therapy in improving the psychopathological
condition of adult outpatients. In addition, the implications for the patient-centered
perspective were also discussed.
Keywords: music therapy, drug treatments, adult psychiatric outpatients, neuroleptics, antidepressants
INTRODUCTION
It is well known that music is connected to mood and that a certain piece of music can make
people feel blessed, sad, lively, or relaxed (Biasutti, 2015a). The effects of music on a person’s
mindset and well-being are evident, and music has been used in various settings and conditions
to control and improve health conditions (Biasutti and Concina, 2013). Music has been studied
in several therapeutic settings for managing psychological conditions such as anxiety and stress,
and there is strong scientific evidence supporting these positive effects. Music therapy treatments
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are categorized as expressive therapies and non-verbal techniques
for facilitating, expanding and shaping patients’ expression and
communication modes (Manarolo, 2005). The improvement of
these skills provide patients with a comfort zone in which to
express themselves while developing confidence and self-efficacy.
Music therapy treatment may help in shifting from a disease-
centered perspective to a patient-centered perspective in the
psychiatric setting and in determining new dynamics in the
care relationship. Music therapy may facilitate a patient-centered
perspective with an approach based on creativity and personal
empowerment rather than external control of symptoms, as is the
case with drug control.
A patients’ engagement in healthcare is crucial and is
widely recognized as a critical component of a high-quality
health care system (Mead and Bower, 2000; Coulter and
Ellins, 2007; Coulter, 2012; Graffigna et al., 2015). Several
health care institutions at the forefront of policies support the
promotion of a patient-centered perspective (Hibbard et al.,
2004; Barello et al., 2012). The consumer-centered mental health
framework could be used for finding alternative solutions to
complement drug usage in order to improve the symptoms
of patients and thus improve the participation and effective
collaboration of patients in the management of their care
(Lawn et al., 2007; Kreyenbuhl et al., 2009; Kukla et al.,
2013).
There are several advantages for the use of music therapy in
mental health care that can facilitate the shift from a disease-
centered perspective to a patient-centered perspective. Compared
with drug therapies, music therapy can help to improve patients’
symptoms and quality of life in alternative and more holistic
ways. This approach can lead to patients more effectively
engaging in their care management, consequently resulting in
improved health and well-being outcomes, including such effects
as positive recovery attitudes (Loh et al., 2007; Patel et al., 2008;
Livingston et al., 2013).
Background
The current study is focused on how a patient-centered
perspective could be applied in psychiatry using music therapy
as a rehabilitation technique. There are many studies in the
literature that have focused on the effects of music therapy in such
settings as psychiatry. Several reviews and meta-analyses have
shown that music therapy, in combination with drug treatments,
has significant effects on the positive and negative symptoms of
psychosis, depression and the well-being of affected individuals
(Maratos et al., 2008; Gold et al., 2009; Carr et al., 2013). The
positive effects of music therapy have also been observed in the
pathology of schizophrenia (Yang et al., 1998; Talwar et al., 2006).
Jung and Newton (2009) performed a comparative analysis of
the existing literature using the Cochrane database to explore the
effects of 28 alternative therapies for schizophrenia, psychosis,
and bipolar disorder. They noted that music therapy is one
of the four most effective interventions in psychiatry. Other
research has considered the effectiveness of music therapy on
patients’ quality of life and spirituality (Grocke et al., 2014),
among schizophrenic in-patients needing acute care to reduce
negative symptoms and improve interpersonal contact (Ulrich
et al., 2007), and for reducing patients’ depression (Erkkilä et al.,
2011).
The issue of the reduction of drug use by mental health
patients as an effect of the outcomes of music therapy sessions
(which is the subject of the current research) has been regarded
with less interest by researchers, likely because of the difficulty
of accessing such data and the complexity of data retrieval.
Changes in drug treatments are often evaluated secondarily
without being deemed a fundamental aspect of research. Chen
et al. (2014) compared the drug dosages of patients in two groups
(experimental and control) and found similarities in drug intake
between the two groups. However, we argue that drug dosage
should be considered a fundamental variable of research because
it has a significant impact on disease management and because
it involves a number of obvious advantages in an individual’s
treatment.
The literature also discusses how music therapy techniques
can become complementary or adjuvant to drug therapy and
how music therapy can provide psychological support with the
consequent need to carefully consider the scientific evidence of
the effectiveness of music therapy. In a meta-analysis of five
studies, Maratos et al. (2008) compared the efficacy of music
therapy to other therapies, such as drug and psychological
support, and found that in four of the five studies analyzed, a
greater reduction in symptoms of depression was reported among
randomized patients after music therapy compared to those who
received standard care. Similar results have also been highlighted
by Erkkilä et al. (2011). Other studies have shown that in various
types of patients, the therapeutic value of music can lead to a
reduction of the anxiety state and a consequent decrease of drugs
for the control of anxiety (Lepage et al., 2001). Lepage et al. (2001)
found that the use of music resulted in decreased use of sedatives
in interventions involving spinal anesthesia.
Few studies have examined changes in drug treatment as
a result of music therapy interventions. Morgan et al. (2011)
considered variations in drug treatment in patients between
the ages of 17 and 55 years with a diagnosis of schizophrenia,
schizoaffective disorder, and bipolar affective disorder with a
framework of psychotic symptoms in the acute phase after
participating in music therapy sessions. The patients were divided
into two randomized groups: the experimental group, which
participated in four sessions of individual active music therapy,
and the control group, which participated in four sessions of
music listening. Several scales have been proposed for patients
before and after treatment, such as the Brief Psychiatric Rating
Scale and the Calgary Interview Guide for Depression, and the
average weekly patient dose of drugs, such as antipsychotics,
mood stabilizers, benzodiazepines and antidepressants, has been
monitored. There were no significant differences in drug dosage
before and after music therapy treatments, whereas significant
results were found using the Brief Psychiatric Rating Scale. The
outcomes of this research are likely to be related to the short
duration of music therapy treatment.
Literature Review Summary
The background analysis showed the effectiveness of music
therapy treatments in psychiatry and suggested that music
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therapy may provide a means of improving mental health among
psychiatric patients (Yang et al., 1998; Talwar et al., 2006; Maratos
et al., 2008; Gold et al., 2009; Jung and Newton, 2009; Carr et al.,
2013). However, its effects on drug therapy have not been deeply
explored, and no significant reduction in the drug treatment
of patients following music therapy treatments has been shown
(Morgan et al., 2011). The results of the research by Morgan
et al. (2011) were likely influenced by the limited number of
music therapy sessions (only four). Few studies have correlated
the effects of music therapy with drug dosage in the treatment of
psychiatric patients by considering these variables fundamental
in the formulation of the experimental hypotheses. The need
for better methodological control and conditions with a specific
focus on the music therapy approach has also been noted.
Aim of the Study and Research Question
The current research aimed to fill the gaps of previous
research by examining how prolonged group music therapy
may affect drug assumption in adult psychiatric outpatients
in a controlled trial. The research methodology adopted a
quantitative approach using an experimental design that included
an experimental group (MT) and a control group (CTR).
The MT group participated in group music therapy sessions,
whereas the CTR group experienced other non-expressive group
activities (psycho-educational group activities on well-being).
The research resulted in an analysis of drug dosages for
all of the patients by consulting their medical records. The
pharmacological treatments were classified according to the
following four primary categories: neuroleptics, benzodiazepines,
mood stabilizers, and antidepressant medications. The following
research question was considered: does participation in group
music therapy sessions affect drug dosage in adult outpatients
with serious psychiatric problems?
MATERIALS AND METHODS
Participants
The sample consisted of 27 psychiatric outpatients ranging in age
from 27 to 57 years (average age, 42 years) who were followed
at an outpatient Mental Health Centre (MHC) in the northeast
region of Italy. Participants were recruited by considering
all the patients under the care of the MHC. The inclusion
criteria required that the participants’ primary diagnoses
were F20 (schizophrenia), F25 (schizoaffective disorders), F31
(bipolar affective disorder), F32 (depressive episode), and
F60 (specific personality disorders) according to the ICD-
10 classification. These inclusion criteria were determined
by the need to focus the research on psychiatric disease.
Other types of diseases were not considered, such as drinking
problems, post-traumatic stress disorder, and substance misuse
disorder. Additionally, the outpatients were required to have
pharmacological treatments in the following four primary drug
categories: neuroleptics, benzodiazepines, mood stabilizers, and
antidepressant medication. Fourteen participants were assigned
to the MT group, and 13 were randomly assigned to the CTR
group. Only the MT group participated in the group music
therapy activities, whereas the CTR group experienced other non-
expressive group activities (psycho-educational group activities
on well-being).
We assessed 132 participants for eligibility. Of this group, 23
were deleted because they did not meet the inclusion criteria. Of
the remaining 109 participants (132 – 23 = 109), 16 participants
were assigned to the music therapy activities. Of the remaining
93 subjects (109 – 16 = 93), a group of 16 participants was
randomly extracted for the control group. The process of random
assignment was performed by an independent collaborator who
was not responsible for determining the eligibility of the patients.
The random assignment was determined with a random number
generator with the use of sequentially numbered, opaque, sealed
envelopes (SNOSE). A flow chart of the referral process is
presented in Figure 1.
The participants had been admitted to the MHC in a day-
care community. Their medical records had been established for
at least 6 years. They were not in an acute or subacute state,
and they had no hospitalisations in the previous 6 months. The
participants of the two groups had similar characteristics with
regard to age, gender, prognostic factors, and psychiatric disease.
The age of the 14 psychiatric outpatients of the MT group ranged
from 29 to 57 years (average age of 43 years), and the group
was composed of seven males and seven females. The age of the
13 psychiatric outpatients of the CTR group ranged from 27 to
55 years (average age of 41 years), and the group was composed
of five males and eight females. A group comparison using the
χ2 test showed no significant differences between the MT group
and the CTR group with regard to age, gender, and psychiatric
disease.
The psychiatric participants were diagnosed with psychosis,
bipolar disorder, and/or borderline personality disorder, and
all displayed psychotic features. The patients involved in the
study were considered serious with regard to psychosis. The
participants were independent and autonomous. The majority
of them lived with their family of origin. Of the participants,
63% were men, and 22% were married and living with their
spouse, whereas only one was living in a community apartment.
Regarding socio-cultural status, 14% had a university degree, and
37% had a high school diploma, and only 37% had a job.
Music Therapy Activities
The music therapy activities were conducted in group sessions
of 2 h each on a weekly basis throughout 1 year for a total of
48 sessions. The music therapy activities were based on active
techniques in which the participants were asked to play and
improvise. Improvisation was based on the processes outlined
by Biasutti and Frezza (2009) and Biasutti (2015b). The purpose
of the group music therapy activities was to constitute a stable
human therapeutic frame capable of supporting the relevant
manifestations of suffering expressed by the outpatients. “The
therapeutic process is based on the mutual construction of
meaning of emerging thoughts, images, emotional content,
and expressive qualities that often originate from the musical
experience and are then conceptualized and further processed
in the verbal domain” (Erkkilä et al., 2011, p. 134). The setting
consisted of chairs arranged in a circle with the instruments
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FIGURE 1 | Flow chart of the referral process.
(e.g., djembe, darbuka, cymbals, wood blocks, rattles, bongos, and
maracas) placed in the center.
The music therapy team, led by a music therapist, included
a psychiatrist-psicotherapist, and a nurse. In addition to these
professionals, a volunteer psychologist and a music therapist
trainee attended the sessions. The large number of operators
was necessary for the validity of the setting and is a constitutive
feature of group music therapy activities (Manarolo, 2006). All
of the members of the music therapy team participated in the
group sessions and were involved in the musical productions.
At the end of each session, a reflective discussion was scheduled
in which the participants had the opportunity to express the
feelings they experienced during the group music therapy session.
Moreover, there was a monthly meeting of the music therapy
team for sharing and discussing the progress of the sessions. The
14 participants in the MT group were divided into two groups
of eight and six participants who had separate group sessions
to ensure a lower dispersion and greater attention by the music
therapy team. The two groups were conducted by the same
music therapy team using the same music therapy methodology.
These groups were designed for a maximum of 10 participants
(Manarolo, 2006).
Procedure
The data were collected and the patients’ medical records over
a 1-year period were analyzed to extrapolate the historical
drug dosage for each patient. The data collection transpired
over a sufficiently long period of time to appreciate the
general course of drug therapy. Pre- and post-music therapy
periods were distinguished. The pre-music therapy period
was when the patients did not attend the music therapy
sessions. This period was useful for collecting baseline data
on drug dosage. The post-music therapy period was after the
end of the music therapy sessions. The patients participated
in an ongoing music therapy activity for a year, which is
considered the minimum duration for detecting significant
results of music therapy (Gold et al., 2009). Before starting
and at the end of the activities, the dosages of the drugs
taken by the patients on a daily basis were noted, and
the total quantity of drugs consumed in a month was
calculated. Medications were controlled by psychiatrists, who
determined whether doses should be increased or decreased.
Medications were controlled every 2 weeks, and this control
was independent of the music therapy sessions offered.
The psychiatrists who controlled the drug dosage of the
participants were blind to the research procedures and to
the participants’ allocation, and they had no role in the
research.
With regard to drugs, the participants were administered a
variety of drugs summarized into 35 types, which are placed in the
following four broad categories: neuroleptics, benzodiazepines,
mood stabilizers, and antidepressants. To obtain standardization
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of the data, the dosage was reported in Mg and was later
converted into a percentage by dividing the daily dose into the
maximum dosage per day. The mean daily dose for the long-
acting depot drugs, which were taken every 2/4 weeks, was
also calculated. Additionally, the adult outpatients participated
in monthly individual monitoring visits in which their clinical
picture was verified. The data from these visits were used to
triangulate the results.
This study was conducted in accordance with the
recommendations of the British Psychological Society with
informed consent from all subjects. All subjects gave informed
consent in accordance with the Declaration of Helsinki. For
medical record consultations, the director of the MHC obtained
the proper authorisation.
RESULTS
Methods for Data Analysis
The data collected included the changes over time of drug
treatments for the four types of drugs during pre- and post-
conditions. For data analysis, the statistical program SPSS 22
was used. The descriptive statistics were computed, and the
Kolmogorov–Smirnov normality test was conducted to verify
whether the distributions of the considered pharmacological
groups were normal. The results showed that all of the
categories met the criteria of normality, with the exception
of mood stabilizers at p < 0.05. For this category, the non-
parametric Friedman Test was performed, which allowed us
to separately isolate the time effect within the groups. To
calculate the other drug categories, a paired t-test was used
to compare the MT and CTR groups in the pre- and post-
conditions. In addition, a group comparison of the drug dosages
at baseline was performed, and no group differences were
found.
Drug Treatment
Neuroleptics
Changes in the monthly dosage of neuroleptics for the MT group
and the CTR group in the month before the commencement of
music therapy and after the group music therapy intervention are
shown in Figure 2. The two groups had different trends over time
with regard to the doses of neuroleptics: the MT group decreased,
whereas the CTR group increased. Paired t-tests showed that
these changes were significant in both groups: the MT group with
t = 2.28, df = 13, p < 0.040, and the CRT group with t = −2.32,
df= 12, p < 0.039.
Benzodiazepines
Changes in the monthly dosage of benzodiazepines for the
MT group and the CTR group in the month before the
commencement of group music therapy and after the music
therapy intervention are shown in Figure 2. There was no
significant difference (paired t-test, p > 0.05) between the MT
group and the CTR group. The benzodiazepines exhibited a
similar trend in both groups, and the drug dosage appeared to
be stable over time.
Mood stabilizers
Changes in the monthly dosage of mood stabilizers for the
MT group and the CTR group in the month before the
commencement of music therapy and after the group music
therapy intervention are shown in Figure 2. The non-parametric
Friedman test was computed for the mood stabilizers, which
showed no significant differences in drug dosage over the two
periods for the MT and CTR groups.
Antidepressants
Changes in the monthly dosage of antidepressants for the
MT group and the CTR group in the month before the
commencement of music therapy and after the group music
FIGURE 2 | Changes from baseline (PRE) to post-intervention (POST) in the dosage of the four drug categories for the MT group (n = 14) and the CTR
group (n = 13).
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therapy intervention are shown in Figure 2. The drug dosage
displayed a similar trend in both groups, but the CTR group
increased more than the MT group. This difference is evident
in the paired t-tests, which showed a significant change only
for CRT group with t = −2.56, df = 12, p < 0.025, whereas
the MT group reported no significant difference (paired t-test,
p > 0.05).
DISCUSSION
The present study evaluated the effects of a music therapy
intervention on drug dosages in adult psychiatric outpatients.
Doses of neuroleptics decreased significantly in the MT group
and increased significantly in the CTR group. Doses of
antidepressants did not change significantly in the MT group
but increased significantly in the CTR group. In contrast,
benzodiazepines and mood stabilizers did not demonstrate
significant changes in either group. The adult outpatients
participated in monthly individual monitoring visits in which
their clinical picture was verified. The data from these
visits showed an improvement or no worsening of their
clinical picture during the group music therapy activities,
confirming the results of the diminished drug dosage of
neuroleptics. Neuroleptics are an essential drug therapy for
psychiatric patients who display symptoms of psychosis, and
a significant difference between the MT and the CTR groups
emerged. The dosage in the MT group tended to decrease
significantly, whereas the dosage in the CTR group increased
significantly. The results provide evidence that a group music
therapy treatment in combination with standard care, including
pharmacological treatment, can affect the dose of neuroleptics
(reducing or stabilizing their consumption) and can enhance
the improvement of the clinical picture. The data in the
present study are in contrast to the findings by Morgan
et al. (2011), who reported no significant differences in the
dosage of neuroleptics between the experimental and control
groups. These differences likely relate to the different number
of music therapy sessions in the study by Morgan et al.
(2011) compared to the present research. A more extensive
explanation is due to the nature of neuroleptics that are
used in the treatment of schizophrenia and in diseases such
as bipolar disorder, depressive episodes with psychotic onset,
and personality disorders. These drugs act to reduce positive
symptoms, such as hallucinations, deliria, aggressiveness, and
excitement, and have less direct effects on negative symptoms,
such as ideational impoverishment, autism, depression, and
withdrawal into oneself. Active music therapy plays an important
role in reducing the symptoms of psychosis, such as auditory
hallucinations, deliria and psychomotor agitation, schizophrenia,
and schizoaffective disorders, in patients suffering major
depressive disorders. Research has analyzed patients with
diagnoses similar to those who participated in this study. It
could be argued that group music therapy may have induced
the attenuation of positive symptoms as well as negative ones,
favoring the likelihood of reduction in the daily dose of the
drug.
Regarding benzodiazepines, no significant differences were
found for the MT and CTR groups. This observation likely
depends on the characteristics of the drug. Benzodiazepines are
used as muscle relaxants and are effective for treating symptoms
such as anxiety and agitation. They are used for anxiety
disorders and depression as well as psychotic disorders, such as
schizophrenia. The literature emphasizes that treatment using
benzodiazepines should be cyclical; the dose cannot be increased
for a period of time, and the drug is typically administered
continuously for a relatively short period (Dell’osso and Lader,
2013).
The increase in antidepressant therapy corresponds to the
reduction of secondary neuroleptic therapy and to the greater
stability of the basis of the psychotic framework. This is a fact that
might suggest a maturing capacity of introspection and insight in
patients who are able to address greater awareness of the disease
and related depressive experiences. This hypothesis could also be
related to the induction of more anxious aspects and to the use of
benzodiazepines.
With regard to mood stabilizers, the data did not respond
to the normality criteria and were subjected to non-parametric
tests that showed no significant differences for the MT and
CTR groups. It is useful to remember that the changes
in dosages for this type of drug are usually less “pointed”
than the other categories evaluated because the mechanism
of action requires a long time to achieve a therapeutic
effect.
These results provide evidence that music therapy can stabilize
or reduce the daily amount of drugs administered to psychiatric
patients. This observation contrasts with the outcome of Morgan
et al. (2011), who did not find significant differences between
groups for mood stabilizers.
The other aspects that may have contributed to the positive
results of this study include the number of sessions, the music
therapy technique and the reflective discussion at the end
of the session. The subjects attended 48 sessions within a
year lasting 2 h each, which is a suitable number according
to the literature that suggests that 16 to 51 sessions are
adequate to obtain a positive result (Gold et al., 2009).
The music therapy technique was an active approach (i.e.,
the patients were asked to actively participate in the music
performance) and has been considered the most significant
means for treating severely ill psychiatric patients (Manarolo,
2005). These methods are considered effective because patients
have the opportunity to express feelings that they would
not be able to explain in any other way. Another factor is
the reflective discussion employed at the end of the music
therapy sessions, which allows patients to think about the
content that emerged during the sessions and share their
thoughts with the group (Bruscia, 1998; Erkkilä et al., 2011).
The discussion is a crucial aspect in which the effects of
the sound-musical element allow the patient to express or
verbalize latent content of which the patient is unaware.
This phase, which is considered critical and therapeutic, is
supported by the psychiatrist and the entire music therapy
team who act as a container for the patient’s emotional
reactions.
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CONCLUSION AND RESEARCH
PERSPECTIVES
The results of this research have demonstrated the long-
term effectiveness of group music therapy activities with adult
outpatients with serious psychiatric issues. In this research,
the most relevant analyzed drugs were neuroleptics and
antidepressants. These drugs are more potent than other drugs,
both in terms of their effects and their side effects. The remaining
two types of drugs, mood stabilizers and benzodiazepines, have
different characteristics and are not indicative of psychotic
pathology. Psychotic drugs are crucial in the treatment course
of a psychiatric condition; however, they have several side effects
that reduce the patient’s quality of life physically, such as tremors,
fatigue, and drowsiness, and socially, such as flattened emotional
and social spheres, decreased motivation in participating in daily
activities, and a sense of isolation. Group music therapy was
effective in controlling psychotic symptoms and successfully
reducing the dosage of neuroleptics, thus indicating greater
stability in the patient’s clinical picture, which was a significant
achievement. The music therapy intervention has the advantage
of no side effects and may be beneficial to improving patients’
quality of life (Grocke et al., 2014) by reducing the drug dosage.
The data presented in this study are encouraging considering
that the patients’ characteristics are similar to the clinical picture
of severe psychiatric issues. For these patients, continuity in
attendance at music therapy sessions is already a significant
indicator of success because there was a sharp drop-out in
participation for other activities proposed by the MHC of the
current research. This research should be considered a pilot study
with a limited number of patients. Several limitations could be
discussed, such as the low sample size and the measurement of
the psychophysical conditions of the outpatients. The data are
significant and provide ideas for the continuation of research;
however, the data should be validated with a larger group of
subjects before generalization. In addition, a set of tools could
be associated to measure the enhancement of the psychophysical
conditions of the outpatients. The data could be verified in
additional research with regard to whether these activities might
induce persistent and meaningful effects in combination with
drug treatments and how music therapy might limit drug usage.
Other aspects that could be explored in future trials include a
better understanding of the relationship between the patient and
the therapeutic process in relation to individual diseases and the
different contexts in which the patient is placed.
Implications for the Patient-Centered
Perspective
The results of the current research could also be discussed in the
framework of the patient-centered perspective considering two
main points: (1) the potential role of music therapy in providing
care that is more holistic and aligned with a patient-centered
perspective; and (2) the potential virtuous cycle of symptom
reduction through music therapy.
Considering point one, the positive benefits of music therapy
in improving symptoms and reducing drug usage in light of
the introduction of alternative treatments should be considered.
These treatments can better sustain the quality of life of
patients and add to their resources for improving symptoms.
Furthermore, the findings of the current research provided
evidence of the importance of reducing drug usage through
alternative methods, such as music therapy, in mental health
care. This is an example of how to promote partnerships
with patients as well as patient engagement in their care
management (Lawn et al., 2007; Kreyenbuhl et al., 2009). In
addition, the contribution of music therapy in providing a
more holistic and broader approach to mental health care
and consequently ensuring that mental health care supports
a consumer-centered perspective could be discussed (Lawn
et al., 2007; Kukla et al., 2013; Livingston et al., 2013). In
this framework, mental disorders are considered not only as
something isolated to treat but also as an expression of the
individuality of the person (Loh et al., 2007; Patel et al.,
2008). Moreover, a bio-psychosocial approach could be adopted,
which proposes that symptoms should be treated considering
the biological, psychological, and cultural backgrounds of each
patient.
Regarding point two, the potential virtuous cycle of symptom
reduction through music therapy could be highlighted. In this
case, the reduction of drug use induces an improvement in
patient engagement with an influence on the general well-being
of the person. This cycle could induce a deeper engagement
of patients in their care management and therefore exert
an influence on such aspects as positive recovery attitudes,
higher levels of hope, and fewer symptoms of emotional
discomfort (Loh et al., 2007; Kreyenbuhl et al., 2009; Kukla
et al., 2013; Livingston et al., 2013). In this framework,
music therapy in addition to drug treatment can help in
shifting from a disease-centered perspective to a patient-
centered perspective in the psychiatric setting to establish new
dynamics in the care relationship (Degli Stefani and Xodo,
2015).
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